{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-331147","form_type":"8-K","ticker":"TCRT","cik":"0001107421","company_name":"Alaunos Therapeutics, Inc.","filed_at":"2025-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.806395+00:00","generated_at":"2026-05-16T12:13:26.710453+00:00","sec_items":["1.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Alaunos Therapeutics settles unpaid invoices with MD Anderson for $285,055","bullets":["Settlement resolves disputes over $285,055 in unpaid invoices under 2019 R&D agreement with MD Anderson.","Alaunos to pay in six installments: $142,528 by Dec 30, 2025, then five monthly payments of $28,506 through May 30, 2026.","Mutual general releases exchanged for claims related to unpaid invoices; ongoing protocol 2006-0676 excluded.","CEO Holger Weis signed agreement on Dec 15, 2025; effective date Dec 17, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-331147","json":"https://secwatch.observer/filing/0001193125-25-331147.json","markdown":"https://secwatch.observer/filing/0001193125-25-331147.md","text":"https://secwatch.observer/filing/0001193125-25-331147.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1107421/000119312525331147/0001193125-25-331147-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1107421/000119312525331147/tcrt-20251217.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:13:26.710453+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}